Cpap-Therapy Decreases Glycated Hemoglobin in Patients With Type 2 Diabetes Mellitus and Sleep Apnoea

The review discusses the relevance of the problem of obstructive sleep apnea syndrome in real clinical practice, features of diagnostics and a personalized approach to therapy considering various comorbid conditions, a review of the results of major clinical studies and recommendations. Literature search and selection of clinical studies was carried out for the period from 2000 to 2020 on the websites of the European and Russian Societies of Cardiology, as well as databases PubMed, eLibrary, Google Scholar.

show abstract

Obstructive sleep apnea syndrome and cardiovascular diseases: from diagnosis to personalized therapy (part 1)

Ионин

Павлова

Баранова

2022

jour

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cpap-Therapy Decreases Glycated Hemoglobin in Patients With Type 2 Diabetes Mellitus and Sleep Apnoea

Cited by 1 publication

References 12 publications

Obstructive sleep apnea syndrome and cardiovascular diseases: from diagnosis to personalized therapy (part 1)

Obstructive sleep apnea syndrome and cardiovascular diseases: from diagnosis to personalized therapy (part 1)

Contact Info

Product

Resources

About